By a GenomeWeb staff reporter

This article has been updated to include comments from a Millipore spokesperson.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration disclosed on its website Tuesday that it had sent a warning letter to Millipore in September regarding the firm's promotional materials for influenza diagnostics products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.